These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16086592)

  • 21. Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition.
    Ozvegy-Laczka C; Köblös G; Sarkadi B; Váradi A
    Biochim Biophys Acta; 2005 Feb; 1668(1):53-63. PubMed ID: 15670731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
    Doyle L; Ross DD
    Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and characterization of the N-terminal nucleotide binding domain of an ABC drug transporter of Candida albicans: uncommon cysteine 193 of Walker A is critical for ATP hydrolysis.
    Jha S; Karnani N; Dhar SK; Mukhopadhayay K; Shukla S; Saini P; Mukhopadhayay G; Prasad R
    Biochemistry; 2003 Sep; 42(36):10822-32. PubMed ID: 12962507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells.
    Ozvegy C; Litman T; Szakács G; Nagy Z; Bates S; Váradi A; Sarkadi B
    Biochem Biophys Res Commun; 2001 Jul; 285(1):111-7. PubMed ID: 11437380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characterization and ATP-induced dimerization of the isolated ABC-domain of the haemolysin B transporter.
    Zaitseva J; Jenewein S; Wiedenmann A; Benabdelhak H; Holland IB; Schmitt L
    Biochemistry; 2005 Jul; 44(28):9680-90. PubMed ID: 16008353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations of the central tyrosines of putative cholesterol recognition amino acid consensus (CRAC) sequences modify folding, activity, and sterol-sensing of the human ABCG2 multidrug transporter.
    Gál Z; Hegedüs C; Szakács G; Váradi A; Sarkadi B; Özvegy-Laczka C
    Biochim Biophys Acta; 2015 Feb; 1848(2):477-87. PubMed ID: 25445676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABCG2 (breast cancer resistance protein/mitoxantrone resistance-associated protein) ATPase assay: a useful tool to detect drug-transporter interactions.
    Glavinas H; Kis E; Pál A; Kovács R; Jani M; Vági E; Molnár E; Bánsághi S; Kele Z; Janáky T; Báthori G; von Richter O; Koomen GJ; Krajcsi P
    Drug Metab Dispos; 2007 Sep; 35(9):1533-42. PubMed ID: 17537873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro.
    Cihalova D; Ceckova M; Kucera R; Klimes J; Staud F
    Biochem Pharmacol; 2015 Dec; 98(3):465-72. PubMed ID: 26300056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2.
    Polgar O; Ierano C; Tamaki A; Stanley B; Ward Y; Xia D; Tarasova N; Robey RW; Bates SE
    Biochemistry; 2010 Mar; 49(10):2235-45. PubMed ID: 20088606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
    Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
    Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting Activators and Inhibitors of the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1) Based on Mechanistic Considerations.
    Egido E; Müller R; Li-Blatter X; Merino G; Seelig A
    Mol Pharm; 2015 Nov; 12(11):4026-37. PubMed ID: 26372856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the gout-causing Q141K polymorphism and a CFTR ΔF508 mimicking mutation on the processing and stability of the ABCG2 protein.
    Sarankó H; Tordai H; Telbisz Á; Özvegy-Laczka C; Erdős G; Sarkadi B; Hegedűs T
    Biochem Biophys Res Commun; 2013 Jul; 437(1):140-5. PubMed ID: 23800412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of basic residues within or near the predicted transmembrane helix 2 of the human breast cancer resistance protein in drug transport.
    Cai X; Bikadi Z; Ni Z; Lee EW; Wang H; Rosenberg MF; Mao Q
    J Pharmacol Exp Ther; 2010 Jun; 333(3):670-81. PubMed ID: 20203106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport.
    Tamura A; Watanabe M; Saito H; Nakagawa H; Kamachi T; Okura I; Ishikawa T
    Mol Pharmacol; 2006 Jul; 70(1):287-96. PubMed ID: 16608919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of proline residues in or near the transmembrane helices of the human breast cancer resistance protein (BCRP/ABCG2) that are important for transport activity and substrate specificity.
    Ni Z; Bikadi Z; Shuster DL; Zhao C; Rosenberg MF; Mao Q
    Biochemistry; 2011 Sep; 50(37):8057-66. PubMed ID: 21854076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analysis of ABCG2: role of the GXXXG motif.
    Polgar O; Robey RW; Morisaki K; Dean M; Michejda C; Sauna ZE; Ambudkar SV; Tarasova N; Bates SE
    Biochemistry; 2004 Jul; 43(29):9448-56. PubMed ID: 15260487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2.
    Shukla S; Robey RW; Bates SE; Ambudkar SV
    Biochemistry; 2006 Jul; 45(29):8940-51. PubMed ID: 16846237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).
    Meyer zu Schwabedissen HE; Kroemer HK
    Handb Exp Pharmacol; 2011; (201):325-71. PubMed ID: 21103975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2.
    Pál A; Méhn D; Molnár E; Gedey S; Mészáros P; Nagy T; Glavinas H; Janáky T; von Richter O; Báthori G; Szente L; Krajcsi P
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1085-94. PubMed ID: 17347325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.